Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., [1] neuroscientist Michael Lewis, and organic chemist …

On October 14, 2011, Cephalon Inc. became a wholly owned subsidiary of Teva and ceased to be traded on NASDAQ.

Cephalon, Inc. is an international biopharmaceutical company that specializes in drugs to treat neurological and sleep disorders. The company's activities encompass the discovery, …

Oct 18, 2011 · Teva Pharmaceutical Industries, a global generic drug maker, has acquired Cephalon. Following the merger agreement between the parties, each share of Cephalon …

Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of …

May 2, 2011 · Teva Pharmaceutical Industries Ltd. has agreed to buy Cephalon Inc. for $6.8 billion in a deal that would give the world’s largest generic drug developer a range of …

Cephalon, Inc. (NASDAQ: CEPH) is a U.S. biopharmaceutical company co-founded in 1987 by Dr. Frank Baldino, Jr., a pharmacologist and former scientist with the DuPont Company, who …

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. …

Cephalon seeks to discover, develop and market innovative products to treat neurological disorders, sleep disorders and cancer.

Cephalon is headquartered in Malvern, PA. What is the size of Cephalon? Cephalon has 800 total employees. What industry is Cephalon in? Cephalon’s primary industry is Pharmaceuticals. Is …